Literature DB >> 33257338

Victoria Ng1, Aamir Fazil2, Lisa A Waddell2, Christina Bancej2, Patricia Turgeon2, Ainsley Otten2, Nicole Atchessi2, Nicholas H Ogden2.   

Abstract

Entities:  

Year:  2020        PMID： 33257338      PMCID： PMC7721389          DOI： 10.1503/cmaj.200990-f

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  17 in total

1.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

2.  Screening for SARS-CoV-2 Infection Within a Psychiatric Hospital and Considerations for Limiting Transmission Within Residential Psychiatric Facilities - Wyoming, 2020.

Authors:  Anna W Callaghan; Anna N Chard; Patricia Arnold; Cody Loveland; Noah Hull; Mona Saraiya; Sharon Saydah; Wendy Dumont; Laura G Frakes; Daniel Johnson; ReaAnna Peltier; Clayton Van Houten; A Angelica Trujillo; Jazmyn Moore; Dale A Rose; Margaret A Honein; David Carrington; Alexia Harrist; Susan L Hills
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-07-03       Impact factor: 17.586

3.  Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis.

Authors:  Derek K Chu; Elie A Akl; Stephanie Duda; Karla Solo; Sally Yaacoub; Holger J Schünemann
Journal:  Lancet       Date:  2020-06-01       Impact factor: 79.321

4.  Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study.

Authors:  Nicholas G Davies; Adam J Kucharski; Rosalind M Eggo; Amy Gimma; W John Edmunds
Journal:  Lancet Public Health       Date:  2020-06-02

5.  Presymptomatic Transmission of SARS-CoV-2 - Singapore, January 23-March 16, 2020.

Authors:  Wycliffe E Wei; Zongbin Li; Calvin J Chiew; Sarah E Yong; Matthias P Toh; Vernon J Lee
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-10       Impact factor: 17.586

6.  De-Escalation by Reversing the Escalation with a Stronger Synergistic Package of Contact Tracing, Quarantine, Isolation and Personal Protection: Feasibility of Preventing a COVID-19 Rebound in Ontario, Canada, as a Case Study.

Authors:  Biao Tang; Francesca Scarabel; Nicola Luigi Bragazzi; Zachary McCarthy; Michael Glazer; Yanyu Xiao; Jane M Heffernan; Ali Asgary; Nicholas Hume Ogden; Jianhong Wu
Journal:  Biology (Basel)       Date:  2020-05-16

7.  Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.

Authors:  Zhiliang Hu; Ci Song; Chuanjun Xu; Guangfu Jin; Yaling Chen; Xin Xu; Hongxia Ma; Wei Chen; Yuan Lin; Yishan Zheng; Jianming Wang; Zhibin Hu; Yongxiang Yi; Hongbing Shen
Journal:  Sci China Life Sci       Date:  2020-03-04       Impact factor: 10.372

8.  Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020.

Authors:  Zhen-Dong Tong; An Tang; Ke-Feng Li; Peng Li; Hong-Ling Wang; Jing-Ping Yi; Yong-Li Zhang; Jian-Bo Yan
Journal:  Emerg Infect Dis       Date:  2020-05-17       Impact factor: 6.883

9.  Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries.

Authors:  Kin On Kwok; Florence Lai; Wan In Wei; Samuel Yeung Shan Wong; Julian W T Tang
Journal:  J Infect       Date:  2020-03-21       Impact factor: 6.072

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.